Kelly Financial Services LLC Karyopharm Therapeutics Inc. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024
SELL
$4.45 - $10.63 $10,368 - $24,767
-2,330 Reduced 90.31%
250 $1.46 Million
Q2 2021

Jul 17, 2024
BUY
$8.11 - $11.11 $18,896 - $25,886
2,330 Added 932.0%
2,580 $250,000
Q2 2020

Jul 17, 2024
SELL
$16.6 - $25.25 $12,582 - $19,139
-758 Reduced 75.2%
250 $4.74 Million
Q3 2019

Jul 17, 2024
BUY
$5.66 - $11.85 $5,705 - $11,944
1,008 New
1,008 $9.7 Million

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email